hVIVO plc
OPORF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.55 | -0.00 | -0.06 | 17.49 |
| FCF Yield | 3.93% | 15.09% | 26.36% | -1.79% |
| EV / EBITDA | 9.50 | 3.96 | 4.01 | 37.86 |
| Quality | ||||
| ROIC | 17.32% | 30.16% | 55.04% | -0.66% |
| Gross Margin | 100.00% | 23.26% | 17.89% | 97.39% |
| Cash Conversion Ratio | 0.78 | 1.55 | -43.78 | -5.65 |
| Growth | ||||
| Revenue 3-Year CAGR | 7.35% | 14.98% | 35.01% | 123.91% |
| Free Cash Flow Growth | -34.70% | -17.49% | 734.78% | -174.80% |
| Safety | ||||
| Net Debt / EBITDA | -1.76 | -1.74 | -3.77 | -4.09 |
| Interest Coverage | 13.46 | 65.17 | 45.29 | 2.60 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 107.11 | 83.42 | 1.46 |
| Cash Conversion Cycle | 81.22 | 46.08 | 40.28 | -449.03 |